Reshaping the GLP-1 Economy: A Breaking Consumer Study
About this episode
This episode discusses the transformative effects of GLP-1 medications on consumer behavior and various industries with insights from Lisa W. Miller.
GLP-1 medications like Ozempic® and Wegovy® are transforming far more than weight loss. They're changing how people eat, shop, spend money, dine out, and interact with brands, creating ripple effects across retail, restaurants, healthcare, apparel, and the broader economy. In this episode of We Fixed It, You're Welcome, Aaron Wolpoff and Chino Nnadi sit down with Lisa W. Miller, ex PepsiCo VP Consumer Strategy & Insights and founder of Lisa W. Miller & Associates, to discuss groundbreaking findings from her latest proprietary research on the rapidly evolving GLP-1 economy. With insights from more than 30 industry studies and a survey of 6,500 U.S. consumers, Lisa reveals what businesses need to know as consumer behavior changes in real time. From the surprising rise of male GLP-1 users to the future of retail, employee benefits, and restaurant innovation, this conversation explores why companies that adapt early will likely have a competitive advantage while those that ignore these shifts risk being left behind. What You'll Learn • How GLP-1 medications are reshaping consumer spending habits • Why restaurants, retailers, and grocery brands are being forced to adapt • The…
Topics covered
- GLP-1 medications
- consumer behavior
- retail impact
- restaurant innovation
- weight loss
- male GLP-1 users
- business adaptation
More episodes of We Fixed It. You're Welcome.
- Season 3's Final Fixes
- ChatGPT vs Claude: Which AI is Winning the PR War?
- What Even Is a Podcast Anymore?
- Is Prime Day a Real Holiday Now?
- Brand Collabs: Overplayed or Worth the Hype?
Explore listener stats, chart rankings, contacts and more on the We Fixed It. You're Welcome. podcast page.